Bristol-Myers Squibb Company
BMY
$47.85
$1.302.79%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.02% | 120.62% | -95.91% | -37.19% | -18.96% |
| Total Depreciation and Amortization | -62.13% | -59.45% | -24.50% | 6.47% | 6.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 282.19% | -97.05% | 252.58% | -31.67% | 145.12% |
| Change in Net Operating Assets | 100.63% | -1,044.95% | 49.24% | 486.60% | -39.47% |
| Cash from Operations | 68.40% | -31.05% | 4.40% | 17.68% | 23.26% |
| Capital Expenditure | -37.79% | 8.45% | -14.55% | 5.26% | -1.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 79.24% | 99.61% | 91.91% | -6.75% | -646.20% |
| Divestitures | 0.00% | 0.83% | 38.17% | 3.24% | 39.18% |
| Other Investing Activities | -310.87% | -184.52% | 84.62% | 1,700.00% | 157.50% |
| Cash from Investing | 64.14% | 97.46% | 85.44% | 46.59% | -300.91% |
| Total Debt Issued | -82.21% | -97.69% | -109.59% | 1,050.00% | 183.48% |
| Total Debt Repaid | 79.43% | -- | 100.00% | -- | -1,207.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.70% | -3.80% | -5.00% | -2.10% | -1.67% |
| Other Financing Activities | 283.33% | -6.19% | -- | -58.97% | -111.32% |
| Cash from Financing | 54.36% | -106.78% | -269.80% | 25.35% | -85.14% |
| Foreign Exchange rate Adjustments | 681.82% | 246.67% | -288.46% | 302.63% | -175.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.14% | 124.16% | -37.89% | 286.35% | -387.64% |